To see all protocols that comply with the WHO Essential Medicine List 

Welcome to eviQ

A free resource of evidence-based, consensus driven cancer treatment protocols and information for use at the point of care. eviQ is developed for the Australian context and supports health professionals in the delivery of cancer treatments.

Find out more


Latest news

View all news

Following significant clinician engagement from around Australia, Dihydropyrimidine dehydrogenase (DPD) enzyme deficiency (ID: 1744) has been reviewed and published on eviQ.

At the last BMT reference committee meeting on 26 August 2022 the autologous conditioning germ cell TICE protocols were updated, recommending the use of directly measured glomerular filtration rate (mGFR) instead of an estimated kidney function via the Jelliffe formula to calculate carboplatin dosing.

We've developed a quick video to help explain how the ADDIKD guideline recommendations are being implemented into the eviQ protocols with the expertise of our reference committee members.

Join us online or in-person for free eviQ education sessions on Wednesday 14 June in Adelaide and Whyalla in South Australia.